These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Clinical Profile of Patients with Scleritis in Bangladesh. Rahman Z; Jafarullah O; Huq N; Hasan K; Magesan K; Dutta Majumder P Ocul Immunol Inflamm; 2021 Aug; 29(6):1102-1105. PubMed ID: 32130057 [No Abstract] [Full Text] [Related]
47. Anterior scleritis: three case reports and a review of the literature. Castells DD Optometry; 2004 Jul; 75(7):430-44. PubMed ID: 15296376 [TBL] [Abstract][Full Text] [Related]
48. Factors affecting the resolution of acute non-infectious anterior scleritis. Abdel-Aty A; Kombo N Br J Ophthalmol; 2022 Dec; 106(12):1672-1677. PubMed ID: 34210671 [TBL] [Abstract][Full Text] [Related]
49. Clinical characteristics and efficacy of methotrexate in Japanese patients with noninfectious scleritis. Hiyama T; Harada Y; Kiuchi Y Jpn J Ophthalmol; 2021 Jan; 65(1):97-106. PubMed ID: 33107015 [TBL] [Abstract][Full Text] [Related]
50. Mycophenolate mofetil in the treatment of chronic non-infectious, non-necrotizing scleritis. Kolomeyer AM; Ragam A; Shah K; Jachens AW; Tu Y; Chu DS Ocul Immunol Inflamm; 2012 Apr; 20(2):113-8. PubMed ID: 22409564 [TBL] [Abstract][Full Text] [Related]
51. Comparative study of ophthalmological and serological manifestations and the therapeutic response of patients with isolated scleritis and scleritis associated with systemic diseases. Sousa JM; Trevisani VF; Modolo RP; Gabriel LA; Vieira LA; Freitas Dd Arq Bras Oftalmol; 2011; 74(6):405-9. PubMed ID: 22331111 [TBL] [Abstract][Full Text] [Related]
52. Ocular Pharmacology for Scleritis: Review of Treatment and a Practical Perspective. Stem MS; Todorich B; Faia LJ J Ocul Pharmacol Ther; 2017 May; 33(4):240-246. PubMed ID: 28355124 [TBL] [Abstract][Full Text] [Related]
53. Anterior scleritis, scleral thinning, and intraocular pressure measurement. Nessim M; Kyprianou I; Kumar V; Murray PI Ocul Immunol Inflamm; 2005 Dec; 13(6):455-7. PubMed ID: 16321890 [TBL] [Abstract][Full Text] [Related]
54. Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey. Erkanli L; Akova YA; Guney-Tefekli E; Tugal-Tutkun I Cornea; 2010 Jan; 29(1):26-33. PubMed ID: 19907295 [TBL] [Abstract][Full Text] [Related]
56. Clinical Features and Complications of Scleritis in Chinese Patients. Yang P; Ye Z; Tang J; Du L; Zhou Q; Qi J; Liang L; Wu L; Wang C; Xu M; Tian Y; Kijlstra A Ocul Immunol Inflamm; 2018; 26(3):387-396. PubMed ID: 27849414 [TBL] [Abstract][Full Text] [Related]
57. Diffuse anterior scleritis and secondary glaucoma as a manifestation of adult T-cell prolymphocytic leukemia. Kommaraju KR; Moroi S; Demirci H Cornea; 2014 Aug; 33(8):873-4. PubMed ID: 24977988 [TBL] [Abstract][Full Text] [Related]
58. Efficacy and safety of immunosuppressive agents in the treatment of necrotising scleritis: a retrospective, multicentre study in Korea. Jeon HS; Hyon JY; Kim MK; Chung TY; Yoon KC; Kim JY; Na KS; Kim HJ; Kim TI; Lee JS; Lee HK; Song JS Br J Ophthalmol; 2016 Aug; 100(8):1066-70. PubMed ID: 26598577 [TBL] [Abstract][Full Text] [Related]
59. Peripheral Subretinal Mass Complicating Necrotizing Anterior Scleritis in a Patient with Granulomatosis with Polyangiitis. Alhazzani AA; Tobaigy MF; Aldofyan MI; AlBloushi AF Middle East Afr J Ophthalmol; 2022; 29(3):159-162. PubMed ID: 37408726 [TBL] [Abstract][Full Text] [Related]